DK0769293T3 - Anvendelse af mindst en beta-adrenerg agonist som substans P-antagonist - Google Patents

Anvendelse af mindst en beta-adrenerg agonist som substans P-antagonist

Info

Publication number: DK0769293T3
Authority: DK; Denmark
Prior art keywords: antagonist; beta; substance; adrenergic agonist; adrenergic
Prior art date: 1995-10-23

Application number

DK96402098T

Other languages

English (en)

Inventor

Lacharriere Olivier De

Lionel Breton

Jacques Leclaire

Original Assignee

Oreal

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-10-23

Filing date

1996-10-01

Publication date

1999-12-06

1996-10-01 Application filed by Oreal filed Critical Oreal

1999-12-06 Application granted granted Critical

1999-12-06 Publication of DK0769293T3 publication Critical patent/DK0769293T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Dermatology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Birds (AREA)
Toxicology (AREA)
Cosmetics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

DK96402098T 1995-10-23 1996-10-01 Anvendelse af mindst en beta-adrenerg agonist som substans P-antagonist DK0769293T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9512447A FR2740040B1 (fr)	1995-10-23	1995-10-23	Utilisation d'au moins un agoniste beta-adrenergique en tant qu'antagoniste de substance p

Publications (1)

Publication Number	Publication Date
DK0769293T3 true DK0769293T3 (da)	1999-12-06

Family

ID=9483809

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96402098T DK0769293T3 (da)	1995-10-23	1996-10-01	Anvendelse af mindst en beta-adrenerg agonist som substans P-antagonist

Country Status (14)

Country	Link
US (2)	US5958432A (da)
EP (1)	EP0769293B1 (da)
JP (1)	JP3636473B2 (da)
AR (1)	AR004052A1 (da)
BR (1)	BR9611302A (da)
CA (1)	CA2222311C (da)
DE (1)	DE69603681T2 (da)
DK (1)	DK0769293T3 (da)
FR (1)	FR2740040B1 (da)
HU (1)	HUP9900511A3 (da)
NO (1)	NO312273B1 (da)
PL (1)	PL186366B1 (da)
RU (1)	RU2169552C2 (da)
WO (1)	WO1997015281A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5948972A (en) *	1994-12-22	1999-09-07	Kla-Tencor Corporation	Dual stage instrument for scanning a specimen
US6503953B2 (en)	2000-07-26	2003-01-07	Atopic Pty Ltd.	Methods for treating atopic disorders
ITPD20010187A1 (it) *	2001-07-23	2003-01-23	Cutech Srl	Trattamento del follicolo polifero, in particolare contro la caduta dei capelli
EP1295599A1 (en) *	2001-09-21	2003-03-26	Boehringer Ingelheim International GmbH	Method for the treatment of prevention of atopic dermatitis
US20030219573A1 (en) *	2002-03-27	2003-11-27	Torgny Falk	Absorbent product
US7345065B2 (en) *	2002-05-21	2008-03-18	Allergan, Inc.	Methods and compositions for alleviating pain
RU2220738C1 (ru) *	2002-08-30	2004-01-10	Гапонюк Петр Яковлевич	Средство для лечения ринита
US8343519B2 (en) *	2003-02-19	2013-01-01	L'oreal S.A.	Chemical enhancer and method
EP1613266A4 (en) *	2003-04-15	2009-05-06	Theraquest Biosciences Llc	METHOD FOR TREATING PAIN AND COMPOSITIONS FOR USE THEREOF
WO2006054513A1 (ja) *	2004-11-19	2006-05-26	Kissei Pharmaceutical Co., Ltd.	神経因性疼痛の予防又は治療剤
MX2007012794A (es) *	2005-04-13	2008-02-22	Astion Pharma As	Composiciones para el tratamiento de trastornos del tejido conectivo de la piel.
CA2715110A1 (fr) *	2008-01-18	2009-09-17	Centre National De La Recherche Scientifique (Cnrs)	Composes utilisables pour le traitement de douleurs neuropathiques
GB0805535D0 (en)	2008-03-27	2008-04-30	Univ Leicester	Scar prevention
US8420114B2 (en) *	2008-04-18	2013-04-16	Warsaw Orthopedic, Inc.	Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation
WO2010097381A1 (en) *	2009-02-24	2010-09-02	Novartis Ag	Uses of nk receptor antagonists
GB2513297A (en)	2013-03-08	2014-10-29	Univ Leicester	Methods
JP6659819B2 (ja)	2015-07-09	2020-03-04	ガルデルマ・ソシエテ・アノニム	化学療法に関連する脱毛の軽減方法
JP7152051B2 (ja) *	2018-05-29	2022-10-12	株式会社ナノエッグ	アトピー性皮膚炎を治療または予防するための組成物
CN113613640B (zh) *	2018-09-08	2024-11-29	谭文	肾上腺素能β2受体激动剂R-对映体在治疗炎症性肠病及其肠外疾病的新应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1474316A (en) *	1975-02-12	1977-05-25	Seperic	O-aminoalkyl oximes
US4038417A (en) *	1975-06-19	1977-07-26	Nelson Research & Development Company	Method for treatment of psoriasis
US4525359A (en) *	1982-12-10	1985-06-25	Greenway Frank L Iii	Treatment for selective weight control
US5366731A (en) *	1990-08-24	1994-11-22	Wisconsin Alumni Research Foundation	Cosmetic compositions containing secosterol compounds
IL99368A (en) *	1991-09-02	1996-01-19	Teva Pharma	Preparations for the treatment of psoriasis and atopic dermatitis, which contain the result of xanthine
CA2114968A1 (en) *	1993-02-25	1994-08-26	John Wille	Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity
JPH07258067A (ja) *	1994-03-18	1995-10-09	Kao Corp	浴用剤組成物
FR2719474B1 (fr) *	1994-05-05	1996-05-31	Oreal	Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue.

1995
- 1995-10-23 FR FR9512447A patent/FR2740040B1/fr not_active Expired - Fee Related
1996
- 1996-10-01 JP JP51633197A patent/JP3636473B2/ja not_active Expired - Fee Related
- 1996-10-01 PL PL96324924A patent/PL186366B1/pl not_active IP Right Cessation
- 1996-10-01 HU HU9900511A patent/HUP9900511A3/hu unknown
- 1996-10-01 DK DK96402098T patent/DK0769293T3/da active
- 1996-10-01 CA CA002222311A patent/CA2222311C/fr not_active Expired - Fee Related
- 1996-10-01 WO PCT/FR1996/001530 patent/WO1997015281A1/fr not_active Ceased
- 1996-10-01 BR BR9611302A patent/BR9611302A/pt not_active IP Right Cessation
- 1996-10-01 EP EP96402098A patent/EP0769293B1/fr not_active Expired - Lifetime
- 1996-10-01 RU RU97121883/14A patent/RU2169552C2/ru not_active IP Right Cessation
- 1996-10-01 DE DE69603681T patent/DE69603681T2/de not_active Expired - Fee Related
- 1996-10-21 AR ARP960104829A patent/AR004052A1/es not_active Application Discontinuation
- 1996-10-23 US US08/731,967 patent/US5958432A/en not_active Expired - Fee Related
1997
- 1997-12-30 NO NO19976143A patent/NO312273B1/no unknown
1999
- 1999-05-12 US US09/310,099 patent/US6267972B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
NO976143L (no)	1998-06-03
PL186366B1 (pl)	2003-12-31
JP3636473B2 (ja)	2005-04-06
EP0769293A3 (fr)	1997-05-02
EP0769293B1 (fr)	1999-08-11
MX9710475A (es)	1998-08-30
WO1997015281A1 (fr)	1997-05-01
FR2740040A1 (fr)	1997-04-25
DE69603681D1 (de)	1999-09-16
NO312273B1 (no)	2002-04-22
EP0769293A2 (fr)	1997-04-23
HUP9900511A3 (en)	2000-09-28
CA2222311C (fr)	2006-11-28
PL324924A1 (en)	1998-06-22
RU2169552C2 (ru)	2001-06-27
JP2000503628A (ja)	2000-03-28
DE69603681T2 (de)	1999-11-25
BR9611302A (pt)	1999-03-30
CA2222311A1 (fr)	1997-05-01
NO976143D0 (no)	1997-12-30
FR2740040B1 (fr)	1997-12-05
US6267972B1 (en)	2001-07-31
US5958432A (en)	1999-09-28
AR004052A1 (es)	1998-09-30
HUP9900511A2 (hu)	1999-07-28

Publication	Publication Date	Title
DK0769293T3 (da)	1999-12-06	Anvendelse af mindst en beta-adrenerg agonist som substans P-antagonist
FI964576A7 (fi)	1996-11-15	Uusia agonistiyhdisteitä
DK1019077T4 (da)	2011-03-07	Hidtil ukendte exendinagonistforbindelser
NO960081L (no)	1996-07-10	Östrogen-agonist/antagonister
ID24836A (id)	2000-08-24	Agonis prostaglandin
DK0722736T3 (da)	2001-04-02	Topisk sammensætning indeholdende en antagonist for substans P
PT1009732E (pt)	2003-10-31	1-amino-alquilciclo-hexanos antagonistas do receptor nmda
DE69800895D1 (de)	2001-07-19	Interleukin-1 Rezeptor Antagonist beta (il-1rabeta)
ID23168A (id)	2000-03-23	Reseptor anatagonis vitronektin
PT1036072E (pt)	2004-08-31	Antagonistas de receptores de trombina
FI960516A7 (fi)	1996-08-07	Substituoituja bifenyylisulfonamidiendoteliiniantagonisteja
EE04141B1 (et)	2003-10-15	5-HT tagasihaarde inhibiitori kombinatsioon h5-HT1B antagonisti või osalise agonistiga
BR9505382A (pt)	1997-10-28	Utilização de ao menos um antagonista de substáncia P
NO20004668D0 (no)	2000-09-19	1-(3-heteroarylpropyl- eller -prop-2-enyl)-4- benzylpiperidiner anvendt som NMDA-reseptorantagonister
MA26890A1 (fr)	2004-12-20	Metabolites agonistes/ antagonistes d'oestrogenes
DK0696194T3 (da)	2002-10-07	Anvendelse af indolderivater som 5HT1-antagonister
DK0854867T3 (da)	2002-12-02	Tetrahydroquinoliner som NMDA-antagonister
ID26086A (id)	2000-11-23	Ligan-ligan reseptor 5ht1 azabisiklik
IS4597A (is)	1997-10-22	Ný lyfjafræðileg notkun AII-viðtaka mótlyfja
BR9505392A (pt)	1997-10-28	Utilizações de ao menos um antagonista de substância P
DE69911964D1 (de)	2003-11-13	Leistungsmessung von fernmeldesystemen
DK0944601T3 (da)	2003-06-10	Heterocykliske quanidinylaminoforbindelser som alfa-2-adrenoceptoragonister
DK0786002T3 (da)	2005-09-26	Intracellulær isoform af interleukin-1-receptorantagonisten
FI972558A7 (fi)	1997-06-16	Uusi reseptori
KR950027351U (ko)	1995-10-18	반목 항타장치